FCOMV
Foresite Capital Opportunity Management V Portfolio holdings
AUM
$33.3M
This Quarter Return
-43.82%
1 Year Return
-46.98%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$71.4M
AUM Growth
+$71.4M
(-52%)
Cap. Flow
-$4.62M
Cap. Flow
% of AUM
-6.47%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
Enanta Pharmaceuticals
ENTA
|
$1.62M |
Top Sells
| 1 |
HLTH
Cue Health Inc. Common Stock
HLTH
|
$5.71M |
| 2 |
Cullinan Oncology
CGEM
|
$525K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $37.7M | 52.85% |
5,227,307
| – | – |
|
2
Quantum-Si Incorporated
QSI
$219M
| $7.48M | 10.47% |
1,598,125
| – | – |
|
|
THRX
3
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $5.41M | 7.57% |
468,820
| – | – |
|
|
HLTH
4
DELISTED
Cue Health Inc. Common Stock
HLTH
| $4.14M | 5.79% |
641,483
-885,620
| -58% | -$5.71M |
|
|
5
Cullinan Oncology
CGEM
$442M
| $3.46M | 4.85% |
330,836
-50,166
| -13% | -$525K |
|
6
Adicet Bio
ACET
$60.9M
| $3.4M | 4.75% |
170,000
| – | – |
|
7
Disc Medicine
IRON
$2.13B
| $3.39M | 4.74% |
2,435,125
| – | – |
|
|
KNTE
8
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $3.28M | 4.6% |
291,667
| – | – |
|
|
9
Enanta Pharmaceuticals
ENTA
$193M
| $1.62M | 2.27% |
+22,750
| New | +$1.62M |
|
10
Compass Therapeutics
CMPX
$476M
| $1.51M | 2.11% |
1,100,000
| – | – |
|